These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8521685)

  • 21. Pilot study comparing recombinant erythropoietin alone with erythropoietin plus recombinant granulocyte-macrophage colony-stimulating factor for treatment of the anemia of prematurity.
    Christensen RD; Hunter DD; Ohls RK
    J Perinatol; 1994; 14(2):110-3. PubMed ID: 8014692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythropoietin in the pathogenesis and treatment of neonatal anemia.
    Strauss RG
    Transfusion; 1995 Jan; 35(1):68-73. PubMed ID: 7998075
    [No Abstract]   [Full Text] [Related]  

  • 24. Erythropoietin to prevent and treat the anemia of prematurity.
    Ohls RK
    Curr Opin Pediatr; 1999 Apr; 11(2):108-14. PubMed ID: 10202619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?
    Meyer MP; Haworth C; McNeill L
    S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia of prematurity: progress and prospects.
    Shannon KM
    Am J Pediatr Hematol Oncol; 1990; 12(1):14-20. PubMed ID: 2178457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HuEPO treatment of anemia in preterm infants].
    Galligani L; Perona A
    Minerva Pediatr; 1994 Nov; 46(11):521-6. PubMed ID: 7870011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current controversies in the management of the anemia of prematurity.
    Bishara N; Ohls RK
    Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaemia of prematurity. Epidemiology, management and costs.
    Meyer MP
    Pharmacoeconomics; 1997 Oct; 12(4):438-45. PubMed ID: 10174310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoietin therapy for anemia of prematurity.
    Gallagher PG; Ehrenkranz RA
    Clin Perinatol; 1993 Mar; 20(1):169-91. PubMed ID: 8458164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant erythropoietin for prevention of anemia in preterm infants.
    Obladen M; Maier RF
    J Perinat Med; 1995; 23(1-2):119-26. PubMed ID: 7658311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing the anemia of prematurity: red blood cell transfusions versus recombinant erythropoietin.
    Strauss RG
    Transfus Med Rev; 2001 Jul; 15(3):213-23. PubMed ID: 11471123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [-Development and evaluation of transfusion practices in a population of newborn infants less than 33 weeks gestational age].
    Pierrat V; Lequien P
    Arch Pediatr; 1998 Mar; 5(3):341-2. PubMed ID: 10328009
    [No Abstract]   [Full Text] [Related]  

  • 38. Erythropoietin and neonatal anemia.
    Strauss RG
    N Engl J Med; 1994 Apr; 330(17):1227-8. PubMed ID: 8139633
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of epoetin (erythropoietin) in the anemia of prematurity.
    Novick D; Moore TB; Feig SA
    West J Med; 1995 Apr; 162(4):355-6. PubMed ID: 7747503
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity.
    Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M
    Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.